225 related articles for article (PubMed ID: 3513812)
21. Differential expression of HLA-DR and HLA-DC/DS molecules in a patient with hairy cell leukemia: restoration of HLA-DC/DS expression by (12-0-tetradecanoyl phorbol-13-acetate), 5 azacytidine, and sodium butyrate.
Faille A; Turmel P; Charron DJ
Blood; 1984 Jul; 64(1):33-7. PubMed ID: 6203577
[TBL] [Abstract][Full Text] [Related]
22. Ontogenic and functional implications of the differential expression of HLA-DQ antigens on leukemic cells.
Navarrete C; Fernandez N; Alonso MC; Festenstein H
Hum Immunol; 1986 May; 16(1):52-68. PubMed ID: 3519548
[TBL] [Abstract][Full Text] [Related]
23. Induction of MHC class II molecules HLA-DR, -DP and -DQ and ICAM 1 in human podocytes by gamma-interferon.
Baudeau C; Delarue F; Hé CJ; Nguyen G; Adida C; Peraldi MN; Sraer JD; Rondeau E
Exp Nephrol; 1994; 2(5):306-12. PubMed ID: 7812737
[TBL] [Abstract][Full Text] [Related]
24. Monoclonal antibody against a membrane antigen characterizing leukemic human B-lymphocytes.
Forster HK; Gudat FG; Girard MF; Albrecht R; Schmidt J; Ludwig C; Obrecht JP
Cancer Res; 1982 May; 42(5):1927-34. PubMed ID: 6175400
[TBL] [Abstract][Full Text] [Related]
25. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
26. The MHC class I associated beta 2-microglobulin (beta 2m) light chain is expressed in a molar excess over HLA-ABC and CD1 on the membrane of leukaemic B cells but not leukaemic T cells: evidence for further beta 2m-associated molecules.
Jones RA; Child JA; Master PS; Scott CS
Scand J Immunol; 1991 Jul; 34(1):53-61. PubMed ID: 1712510
[TBL] [Abstract][Full Text] [Related]
27. Phorbol ester-induced differentiation of chronic B lymphocytic leukaemia cells--regulatory impact of autologous and allogeneic accessory cells.
Danersund A; Tötterman TH; Nilsson K; Egle-Jansson I; Kabelitz D; Sjöberg O
Clin Exp Immunol; 1985 Mar; 59(3):644-52. PubMed ID: 3872753
[TBL] [Abstract][Full Text] [Related]
28. [Determination of leukemic B-lymphoma cells with the monoclonal antibody anti-Y 29/55].
Obrecht JP; Gudat F; Forster HK; Albrecht R; Girard MF; Ludwig C; Christen C
Schweiz Med Wochenschr; 1981 Oct; 111(41):1529-31. PubMed ID: 6975994
[TBL] [Abstract][Full Text] [Related]
29. MHC antigen expression in human oral squamous carcinoma cell lines.
Mutlu S; Matthews JB; Midda M; Scully C; Prime SS
J Pathol; 1991 Oct; 165(2):129-36. PubMed ID: 1744799
[TBL] [Abstract][Full Text] [Related]
30. Human gingival Langerhans cells stimulate allogeneic lymphocytes: requirement for MHC class II antigens.
Walsh LJ; Seymour GJ; Powell RN
J Periodontol; 1990 Jun; 61(6):328-33. PubMed ID: 2366140
[TBL] [Abstract][Full Text] [Related]
31. Phorbol ester-induced differentiation of a non-T, non-B leukemic cell line: model for human lymphoid progenitor cell development.
LeBien TW; Bollum FJ; Yasmineh WG; Kersey JH
J Immunol; 1982 Mar; 128(3):1316-20. PubMed ID: 7035564
[TBL] [Abstract][Full Text] [Related]
32. Enhanced expression of human Ia antigens by chronic lymphocytic leukemia cells following treatment with 12-O-tetradecanoylphorbol-13-acetate.
Guy K; Van Heyningen V; Dewar E; Steel CM
Eur J Immunol; 1983 Feb; 13(2):156-9. PubMed ID: 6403357
[TBL] [Abstract][Full Text] [Related]
33. Monoclonal antibody studies in B(non-T)-cell malignancies.
Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
[TBL] [Abstract][Full Text] [Related]
34. Reactivity of the monoclonal antibody RFB1 in chronic B-cell leukaemias.
Melo JV; Catovsky D; Bodger M
Scand J Haematol; 1984 Apr; 32(4):417-22. PubMed ID: 6609424
[TBL] [Abstract][Full Text] [Related]
35. Use of the monoclonal antibody WR17, identifying the CD37 gp40-45 Kd antigen complex, in the diagnosis of B-lymphoid malignancy.
Moore K; Cooper SA; Jones DB
J Pathol; 1987 May; 152(1):13-21. PubMed ID: 3305845
[TBL] [Abstract][Full Text] [Related]
36. A human B lymphocyte antigen (P-76) shared by B-cell chronic lymphocytic leukemia cells and hairy cell leukemia cells.
Kanakura Y; Machii T; Kurata Y; Tamaki T; Yonezawa T; Tarui S; Kitani T
Blut; 1983 May; 46(5):249-59. PubMed ID: 6340759
[TBL] [Abstract][Full Text] [Related]
37. Hairy cell leukaemia: effects of phorbol ester on cell morphology and adherence and comparison with other B-cell neoplasias.
Polliack A; Gurfel D; Or R; Leizerowitz R; Gazitt Y
Scand J Haematol; 1986 Apr; 36(4):358-66. PubMed ID: 3487109
[TBL] [Abstract][Full Text] [Related]
38. Two monoclonal antibodies defining unique antigenic determinants on human B-lymphoma cells.
Howard DR; Eaves AC; Takei F
Cancer Res; 1985 Dec; 45(12 Pt 1):6322-7. PubMed ID: 2415242
[TBL] [Abstract][Full Text] [Related]
39. MHC class II antigen and immunoglobulin expression in spontaneous phenotypic variants of the Burkitt's lymphoma cell line Namalwa.
Guy K; Middleton PG; Docherty LJ; De Angelis CL; Steel CM
Immunology; 1986 Dec; 59(4):603-10. PubMed ID: 3026962
[TBL] [Abstract][Full Text] [Related]
40. Immunoglobulin abnormalities in malignant non-Hodgkin's lymphoma.
Economidou J; Terzoglou K; Anagnostou D; Nikiforakis EM; Papajannis A
Scand J Haematol; 1984 Aug; 33(2):123-8. PubMed ID: 6433436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
